PSIP

Adverse Drug Events (ADE) due to product safety problems, and medication errors due to human factors (HF) are a major Public Health issue. They endanger the patients¿ safety and originate considerable extra hospital costs. Healthcare ICT applications should help reducing the prevalence of preventable ADE, by providing healthcare professionals and patients with relevant knowledge (guidelines, recommendations, etc.).

But their efficiency is impeded by two major drawbacks:

  • lack of reliable knowledge about ADE
  • poor ability of ICT solutions to deliver contextualised knowledge focused on the problem at hand, aggravated by a poor consideration of causative HF.

The objective of the project Patient Safety through Intelligent Procedures in Medication (PSIP) is (1) to facilitate the systematic production of epidemiological knowledge on ADE and (2) to ameliorate the entire medication cycle in a hospital environment.

The first sub-objective, SO, is to innovatively produce knowledge on ADE: to know, as exactly as possible, per hospital, their number, type, consequences and causes, including HF. Data Mining of the structured hospital data bases, and Semantic Mining of Data Collections of free-texts (letters, reports), will give a list of observed ADEs, with frequencies and probabilities, thus giving a better understanding of potential risks.

The second SO is to develop a set of innovative knowledge based on the mining results and to deliver a contextualised knowledge fitting the local risk parameters, in the form of alerts and decision support functions. This knowledge will be implemented in a PSIP-platform independently of existing ICT applications. These applications will connect to the platform to access and integrate the knowledge in their local system. The design and development cycle of the PSIP solution will be HF oriented.

Dissemination plans will be developed taking into account other uses (medical devices, primary and tertiary Healthcare).

For further information, please visit:
http://www.psip-project.eu

Project co-ordinator:
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE

Partners:

  • KITE SOLUTIONS S.N.C. DI DUNNE CATHERINE E C.
  • AALBORG UNIVERSITET
  • ORACLE FRANCE SAS
  • REGION HOVEDSTADEN
  • IBM DANMARK A/S
  • CENTRE HOSPITALIER DE DENAIN
  • VIDAL S.A.
  • IDEEA ADVERTISING SRL
  • EVALAB
  • MEDASYS SA
  • CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
  • ARISTOTLE UNIVERSITY OF THESSALONIKI
  • UMIT - PRIVATE UNIVERSITAET FUER GESUNDHEITSWISSENSCHAFTEN, MEDIZINISCHE INFORMATIK UND TECHNIK GESELLSCHAFT MBH

Timetable: from 01/2008 – to 04/2011

Total cost: € 9.946.770

EC funding: € 7.268.981

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Researchers Use AI to Predict Cancer Ris…

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...